Alex Tarnava

advancing the research on hydrogen therapy, Dr. LeBaron from the Molecular Hydrogen Institute just invited me, and I accepted, to be a... Smartest guy I've ever spoken to about hydrogen. That guy will spin your beanie. If we're going to go into, say, the biochemistry of hydrogen, he is the top in the world. He understands the biochemistry of what hydrogen does in the body better than anyone.

advancing the research on hydrogen therapy, Dr. LeBaron from the Molecular Hydrogen Institute just invited me, and I accepted, to be a... Smartest guy I've ever spoken to about hydrogen. That guy will spin your beanie. If we're going to go into, say, the biochemistry of hydrogen, he is the top in the world. He understands the biochemistry of what hydrogen does in the body better than anyone.

where the only thing I'd say that I have an advantage of him on is I have a better memory and I've read more papers than him. So it's not a contest. Sorry, Tyler. No, no, no. But I mean, he's exponentially more knowledgeable than me in the biochemistry, like exponentially. Right.

where the only thing I'd say that I have an advantage of him on is I have a better memory and I've read more papers than him. So it's not a contest. Sorry, Tyler. No, no, no. But I mean, he's exponentially more knowledgeable than me in the biochemistry, like exponentially. Right.

where the only thing I'd say that I have an advantage of him on is I have a better memory and I've read more papers than him. So it's not a contest. Sorry, Tyler. No, no, no. But I mean, he's exponentially more knowledgeable than me in the biochemistry, like exponentially. Right.

So I'm taking a sliver here, but he's invited me to be the first chairman of the hydrogen research committee under the MHI. So it's a volunteer position. And basically what I'll be doing is I'll be working with the MHI and working with the public in industry. So Dr. LeBaron has hired another PhD, Dr. Grace Russell from the UK, who's published a lot of research on hydrogen.

So I'm taking a sliver here, but he's invited me to be the first chairman of the hydrogen research committee under the MHI. So it's a volunteer position. And basically what I'll be doing is I'll be working with the MHI and working with the public in industry. So Dr. LeBaron has hired another PhD, Dr. Grace Russell from the UK, who's published a lot of research on hydrogen.

So I'm taking a sliver here, but he's invited me to be the first chairman of the hydrogen research committee under the MHI. So it's a volunteer position. And basically what I'll be doing is I'll be working with the MHI and working with the public in industry. So Dr. LeBaron has hired another PhD, Dr. Grace Russell from the UK, who's published a lot of research on hydrogen.

And I know her personally. She's going to be helping research teams fill in NIH grants. to get more funding for hydrogen research in the United States. And I'm going to be working with the public in industry to get more funding, to fund this research, in addition to supplement the NIH grants, and also to do outreach with the universities. Because that was one of the first things I did.

And I know her personally. She's going to be helping research teams fill in NIH grants. to get more funding for hydrogen research in the United States. And I'm going to be working with the public in industry to get more funding, to fund this research, in addition to supplement the NIH grants, and also to do outreach with the universities. Because that was one of the first things I did.

And I know her personally. She's going to be helping research teams fill in NIH grants. to get more funding for hydrogen research in the United States. And I'm going to be working with the public in industry to get more funding, to fund this research, in addition to supplement the NIH grants, and also to do outreach with the universities. Because that was one of the first things I did.

I emailed, like I said, every first and corresponding author on every... study that I could find. So we're going to be doing that and saying, hey, this is where the evidence is. We can help these NIH grants. We can connect with industry to get further funding. And then at the end of the day, once we get partners that have all agreed,

I emailed, like I said, every first and corresponding author on every... study that I could find. So we're going to be doing that and saying, hey, this is where the evidence is. We can help these NIH grants. We can connect with industry to get further funding. And then at the end of the day, once we get partners that have all agreed,

I emailed, like I said, every first and corresponding author on every... study that I could find. So we're going to be doing that and saying, hey, this is where the evidence is. We can help these NIH grants. We can connect with industry to get further funding. And then at the end of the day, once we get partners that have all agreed,

Dr. LeBaron and I are going to review the protocols to make sure that the targets make sense, the methodology makes sense, the dosing makes sense.

Dr. LeBaron and I are going to review the protocols to make sure that the targets make sense, the methodology makes sense, the dosing makes sense.

Dr. LeBaron and I are going to review the protocols to make sure that the targets make sense, the methodology makes sense, the dosing makes sense.

And we've reversed metabolic syndrome, you know, in a double-blind placebo-controlled trial with 60 people over six months. By the way, I'm going to link all these studies into the show notes below. I think it was 21 of 23 measured outcomes. We had a significant clinical and statistically significant impact.

And we've reversed metabolic syndrome, you know, in a double-blind placebo-controlled trial with 60 people over six months. By the way, I'm going to link all these studies into the show notes below. I think it was 21 of 23 measured outcomes. We had a significant clinical and statistically significant impact.

And we've reversed metabolic syndrome, you know, in a double-blind placebo-controlled trial with 60 people over six months. By the way, I'm going to link all these studies into the show notes below. I think it was 21 of 23 measured outcomes. We had a significant clinical and statistically significant impact.